Acrivon Therapeutics, Inc.
ACRV
$2.05
-$0.06-2.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.97M | 22.61M | 24.12M | 25.08M | 25.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.37M | 82.35M | 84.11M | 88.95M | 94.41M |
| Operating Income | -78.37M | -82.35M | -84.11M | -88.95M | -94.41M |
| Income Before Tax | -74.23M | -77.27M | -77.91M | -81.75M | -85.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -74.23 | -77.27 | -77.91 | -81.75 | -85.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.23M | -77.27M | -77.91M | -81.75M | -85.96M |
| EBIT | -78.37M | -82.35M | -84.11M | -88.95M | -94.41M |
| EBITDA | -76.88M | -80.93M | -82.76M | -87.65M | -93.21M |
| EPS Basic | -1.89 | -2.00 | -2.02 | -2.13 | -2.25 |
| Normalized Basic EPS | -1.19 | -1.26 | -1.27 | -1.39 | -1.47 |
| EPS Diluted | -1.89 | -2.00 | -2.02 | -2.13 | -2.25 |
| Normalized Diluted EPS | -1.19 | -1.26 | -1.27 | -1.39 | -1.47 |
| Average Basic Shares Outstanding | 157.79M | 154.41M | 154.03M | 153.61M | 153.16M |
| Average Diluted Shares Outstanding | 157.79M | 154.41M | 154.03M | 153.61M | 153.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |